1-3 of 3
Anna-Sophia Wiekmeijer
Close
Sort by
Journal Articles

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease

Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol, Willem E. Fibbe
Journal: Blood
Blood (2023) 141 (11): 1277–1292.
https://doi.org/10.1182/blood.2022015734
Published: 2023
Includes: Supplemental data
Journal Articles

MEF2C as Novel Oncogene for Early T-Cell Precursor (ETP) Leukemia

Irene Homminga, Rob Pieters, MD, PhD, Anton Langerak, Johan de Rooi, Andrew Stubbs, PhD, Monique Verstegen, Maartje Vuerhard, Jessica Buijs-Gladdines, Clarissa Kooi, Petra Klous, Pieter Van lierberghe, Adolfo Ferrando, Jean-Michel Cayuela, MD, PhD, Brenda Verhaaf, Berna Beverloo, Martin A. Horstmann, MD, Valerie de Haas, Anna-Sophia Wiekmeijer, Karin Pike-Overzet, Frank Staal, Wouter de Laat, Jean Soulier, MD, PhD, Francois Sigaux, Jules Meijerink
Journal: Blood
Blood (2010) 116 (21): 9.
https://doi.org/10.1182/blood.V116.21.9.9
Published: 2010
Journal Articles

Identification of a Novel T-ALL Entity with NKX2-1/NKX2-2 Rearrangements

Irene Homminga, Rob Pieters, MD, PhD, Anton Langerak, PhD, Johan de Rooi, Andrew Stubbs, PhD, Monique Verstegen, PhD, Maartje Vuerhard, Jessica Buijs-Gladdines, Clarissa Kooi, Petra Klous, Pieter Van lierberghe, PhD, Adolfo Ferrando, MD, PhD, Jean-Michel Cayuela, MD, PhD, Brenda Verhaaf, Berna Beverloo, PhD, Martin A. Horstmann, MD, Valerie de Haas, MD, PhD, Anna-Sophia Wiekmeijer, Karin Pike-Overzet, PhD, Frank Staal, PhD, Wouter de Laat, PhD, Jean Soulier, MD, PhD, Francois Sigaux, MD, PhD, Jules P.P. Meijerink, PhD
Journal: Blood
Blood (2010) 116 (21): 3139.
https://doi.org/10.1182/blood.V116.21.3139.3139
Published: 2010